Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin versus penicillin V for Streptococcus pyogenes tonsillitis/pharyngitis
2014-004631-39Phase 3
- Sponsor
- Sanofi
- Start
- Mar 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in streptococcal pharyngitis, streptococcal tonsillitis and tonsillopharyngitis comparing Telithromycin with Penicillin V (2 arms). Primary endpoint: Percentage of patients according to bacteriological outcome in PPb population.
02
Drugs
telithromycinphenoxymethylpenicillin
03
Conditions
streptococcal pharyngitisstreptococcal tonsillitistonsillopharyngitis
Beyond the preview
Go deeper on 2014-004631-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004631-39.